Hevey MC - Search Results

1

Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein.

Swenson DL, Warfield KL, Kuehl K, Larsen T, Hevey MC, Schmaljohn A, Bavari S, Aman MJ. Swenson DL, et al. Among authors: hevey mc. FEMS Immunol Med Microbiol. 2004 Jan 15;40(1):27-31. doi: 10.1016/S0928-8244(03)00273-6. FEMS Immunol Med Microbiol. 2004. PMID: 14734183 Free article.

2

Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses.

Bavari S, Bosio CM, Wiegand E, Ruthel G, Will AB, Geisbert TW, Hevey M, Schmaljohn C, Schmaljohn A, Aman MJ. Bavari S, et al. J Exp Med. 2002 Mar 4;195(5):593-602. doi: 10.1084/jem.20011500. J Exp Med. 2002. PMID: 11877482 Free PMC article.

3

Genomic differences between guinea pig lethal and nonlethal Marburg virus variants.

Lofts LL, Ibrahim MS, Negley DL, Hevey MC, Schmaljohn AL. Lofts LL, et al. Among authors: hevey mc. J Infect Dis. 2007 Nov 15;196 Suppl 2:S305-12. doi: 10.1086/520585. J Infect Dis. 2007. PMID: 17940965

4

Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus.

Riemenschneider J, Garrison A, Geisbert J, Jahrling P, Hevey M, Negley D, Schmaljohn A, Lee J, Hart MK, Vanderzanden L, Custer D, Bray M, Ruff A, Ivins B, Bassett A, Rossi C, Schmaljohn C. Riemenschneider J, et al. Vaccine. 2003 Sep 8;21(25-26):4071-80. doi: 10.1016/s0264-410x(03)00362-1. Vaccine. 2003. PMID: 12922144

5

Characterization of monoclonal antibodies to Marburg virus (strain Musoke) glycoprotein and identification of two protective epitopes.

Hevey M, Negley D, Schmaljohn A. Hevey M, et al. Virology. 2003 Sep 15;314(1):350-7. doi: 10.1016/s0042-6822(03)00416-1. Virology. 2003. PMID: 14517087 Free article.

6

Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants.

Hevey M, Negley D, Geisbert J, Jahrling P, Schmaljohn A. Hevey M, et al. Virology. 1997 Dec 8;239(1):206-16. doi: 10.1006/viro.1997.8883. Virology. 1997. PMID: 9426460 Free article.

7

Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.

Hevey M, Negley D, Pushko P, Smith J, Schmaljohn A. Hevey M, et al. Virology. 1998 Nov 10;251(1):28-37. doi: 10.1006/viro.1998.9367. Virology. 1998. PMID: 9813200 Free article.

8

Marburg virus vaccines: comparing classical and new approaches.

Hevey M, Negley D, VanderZanden L, Tammariello RF, Geisbert J, Schmaljohn C, Smith JF, Jahrling PB, Schmaljohn AL. Hevey M, et al. Vaccine. 2001 Nov 12;20(3-4):586-93. doi: 10.1016/s0264-410x(01)00353-x. Vaccine. 2001. PMID: 11672925

9

Epitopes involved in antibody-mediated protection from Ebola virus.

Wilson JA, Hevey M, Bakken R, Guest S, Bray M, Schmaljohn AL, Hart MK. Wilson JA, et al. Science. 2000 Mar 3;287(5458):1664-6. doi: 10.1126/science.287.5458.1664. Science. 2000. PMID: 10698744

10

Quantitative studies of heteropolymer-mediated binding of inactivated Marburg virus to the complement receptor on primate erythrocytes.

Nardin A, Sutherland WM, Hevey M, Schmaljohn A, Taylor RP. Nardin A, et al. J Immunol Methods. 1998 Feb 1;211(1-2):21-31. doi: 10.1016/s0022-1759(97)00168-3. J Immunol Methods. 1998. PMID: 9617828

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters